您好,欢迎来到试剂信息网! [登录] [免费注册]
试剂信息网
位置:首页 > 产品库 > Axitinib-d3
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
Axitinib-d3
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
Axitinib-d3图片
规格:98%
分子量:389.49
包装与价格:
包装价格(元)
1mg电议
5mg电议
10mg电议

产品介绍
Axitinib-d3 是氘标记的 Axitinib。Axitinib 是多靶点的酪氨酸激酶抑制剂,抑制 VEGFR1,VEGFR2,VEGFR3, PDGFRβ 的 IC50 值分别为4,20,4,2 nM。
货号:ajcx33222
CAS:1126623-89-9
分子式:C22H15D3N4OS
分子量:389.49
溶解度:N/A
纯度:98%
存储:Store at -20°C
库存:现货

Background:

Axitinib-d3 (AG-013736-d3) is deuterium labeled Axitinib. Axitinib is a multi-targeted tyrosine kinase inhibitor with IC50s of 0.1, 0.2, 0.1-0.3, 1.6 nM for VEGFR1, VEGFR2, VEGFR3 and PDGFRβ, respectively.

[1]. Fenton BM, et al. The addition of AG-013736 to rractionated radiation improves tumor response without functionally normalizing the tumor vasculature. Cancer Res. 2007 Oct 15;67(20):9921-8
[2]. Hu-Lowe DD, et al. Nonclinical antiangiogenesis and antitumor activities of axitinib (AG-013736), an oral, potent, and selective inhibitor of vascular endothelial growth factor receptor tyrosine kinases 1, 2, 3. Clin Cancer Res. 2008 Nov 15;14(22):7272-83
[3]. Allen E, et al. Metabolic Symbiosis Enables Adaptive Resistance to Anti-angiogenic Therapy that Is Dependent on mTOR Signaling. Cell Rep. 2016 May 10;15(6):1144-60.